EVKIF
Get informed when a big investor buys or sells
+ FollowUndervalued by 90.1% based on the discounted cash flow analysis.
| Market cap | $9.37 Billion |
|---|---|
| Enterprise Value | $12.95 Billion |
| Dividend Yield | $1.15 (6.12%) |
| Earnings per Share | $0.57 |
| Beta | 0.53 |
| Outstanding Shares | 466,000,000 |
| P/E Ratio | 48.26 |
|---|---|
| PEG | -104.57 |
| Price to Sales | 0.67 |
| Price to Book Ratio | 1.18 |
| Enterprise Value to Revenue | 0.9 |
| Enterprise Value to EBIT | -153.97 |
| Enterprise Value to Net Income | 43 |
| Total Debt to Enterprise | 0.32 |
| Debt to Equity | 0.5 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data
Evonik Industries AG is a holding company, which engages in the manufacture of specialty chemical products. It operates through the following segments: Nutrition and Care, Resource Efficiency, Performance Materials, Services, and Other O...